Department of Urological Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
J Urol. 2011 Apr;185(4):1198-203. doi: 10.1016/j.juro.2010.11.090. Epub 2011 Feb 22.
Concurrent adrenalectomy during renal surgery for renal cell carcinoma was once routine. More recent data suggest that adrenalectomy should be reserved for tumors 7 cm or greater, particularly those involving the upper pole. We evaluated the radiographic and pathological incidence of adrenal involvement in patients undergoing renal surgery for renal cell carcinoma 7 cm or greater.
Patients who underwent renal surgery for tumors 7 cm or greater between 1999 and 2008 were identified from our kidney cancer registry. We used Fisher's exact test to determine whether radiographic tumor site predicted adrenal involvement. The Kaplan-Meier method and Cox proportional hazard regression models were used to analyze the impact of adrenal resection on outcome.
Of 1,650 patients we identified 179 patients who underwent surgery for renal cell carcinoma 7 cm or greater. Of these patients 91 underwent concurrent total ipsilateral adrenalectomy at renal surgery with pathological adrenal involvement confirmed in 4 (4.4%). Upper pole site did not predict involvement (p = 0.83). Preoperative adrenal imaging was 100% sensitive and 92% specific to detect adrenal involvement by renal cell carcinoma with 100% negative predictive value. No survival advantage was noted on multivariate analysis when comparing patients who underwent adrenal resection to 88 in whom the adrenal gland was spared (p = 0.38).
Synchronous ipsilateral adrenal involvement with renal cell carcinoma is rare even in cases of large and/or upper pole tumors, making routine adrenalectomy unnecessary. Preoperative adrenal imaging is highly sensitive and should inform the decision to perform adrenalectomy more than tumor size or site.
在肾细胞癌的肾切除术时同期行肾上腺切除术曾经是常规操作。最近的数据表明,肾上腺切除术应保留用于 7cm 或更大的肿瘤,特别是那些涉及上极的肿瘤。我们评估了在因肾细胞癌而接受 7cm 或更大的肾切除术的患者中,肾上腺受累的影像学和病理学发生率。
从我们的肾癌登记处确定了 1999 年至 2008 年间因肿瘤 7cm 或更大而接受肾切除术的患者。我们使用 Fisher 精确检验来确定影像学肿瘤部位是否预测肾上腺受累。Kaplan-Meier 方法和 Cox 比例风险回归模型用于分析肾上腺切除术对结果的影响。
在 1650 名患者中,我们确定了 179 名因肾细胞癌 7cm 或更大而接受手术的患者。这些患者中有 91 名在肾手术时同时行同侧全肾上腺切除术,其中 4 名(4.4%)病理证实肾上腺受累。上极部位不能预测受累(p = 0.83)。术前肾上腺影像学检查对诊断肾细胞癌肾上腺受累的敏感性为 100%,特异性为 92%,阴性预测值为 100%。多变量分析比较了行肾上腺切除术的患者和 88 名保留肾上腺的患者,未发现生存优势(p = 0.38)。
即使在大肿瘤或/或上极肿瘤的情况下,同步同侧肾上腺受累也很少见,因此常规肾上腺切除术是不必要的。术前肾上腺影像学检查高度敏感,应根据肿瘤大小或部位来决定是否行肾上腺切除术。